130 related articles for article (PubMed ID: 17932968)
21. Clinical Utility of Biomarkers in IBD.
Rogler G; Biedermann L
Curr Gastroenterol Rep; 2015 Jul; 17(7):26. PubMed ID: 26122247
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
[TBL] [Abstract][Full Text] [Related]
23. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Hartman C; Eliakim R; Shamir R
Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
[No Abstract] [Full Text] [Related]
24. Update of fecal markers of inflammation in inflammatory bowel disease.
Judd TA; Day AS; Lemberg DA; Turner D; Leach ST
J Gastroenterol Hepatol; 2011 Oct; 26(10):1493-9. PubMed ID: 21777275
[TBL] [Abstract][Full Text] [Related]
25. New serologic markers for inflammatory bowel disease diagnosis.
Dotan I
Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
[TBL] [Abstract][Full Text] [Related]
26. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
27. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
Quetglas EG; Mujagic Z; Wigge S; Keszthelyi D; Wachten S; Masclee A; Reinisch W
World J Gastroenterol; 2015 Nov; 21(44):12519-43. PubMed ID: 26640330
[TBL] [Abstract][Full Text] [Related]
28. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
Desreumaux P; Bourreille A; Colombel JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
[No Abstract] [Full Text] [Related]
29. Serologic antiglycan antibodies in inflammatory bowel disease.
Lakatos PL; Papp M; Rieder F
Am J Gastroenterol; 2011 Mar; 106(3):406-12. PubMed ID: 21245832
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
Fisher K; Lin J
World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
[TBL] [Abstract][Full Text] [Related]
31. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
32. Controversies in IBD. Serologic tests are helpful in managing inflammatory bowel disease.
Abreu MT
Inflamm Bowel Dis; 2002 May; 8(3):224-6; discussion 223, 230-1. PubMed ID: 11979146
[No Abstract] [Full Text] [Related]
33. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
34. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].
Igaz I; Szőnyi M; Varga P; Topa L
Orv Hetil; 2014 Mar; 155(13):487-91. PubMed ID: 24659741
[TBL] [Abstract][Full Text] [Related]
35. [Non-invasive follow up of patients with inflammatory bowel diseases].
Nancey S; Roblin X
Rev Prat; 2014 Nov; 64(9):1256-61. PubMed ID: 25638865
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.
Viennois E; Zhao Y; Merlin D
Inflamm Bowel Dis; 2015 Oct; 21(10):2467-74. PubMed ID: 25985250
[TBL] [Abstract][Full Text] [Related]
37. Controversies about the use of serological markers in diagnosis of inflammatory bowel disease.
Xie Q; Gan HT
World J Gastroenterol; 2010 Jan; 16(2):279-80. PubMed ID: 20066751
[TBL] [Abstract][Full Text] [Related]
38. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.
Soubières AA; Poullis A
Inflamm Bowel Dis; 2016 Aug; 22(8):2016-22. PubMed ID: 27416044
[TBL] [Abstract][Full Text] [Related]
39. A critical evaluation of serologic markers for inflammatory bowel disease.
Austin GL; Herfarth HH; Sandler RS
Clin Gastroenterol Hepatol; 2007 May; 5(5):545-7. PubMed ID: 17433787
[No Abstract] [Full Text] [Related]
40. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
Solberg IC; Lygren I; Cvancarova M; Jahnsen J; Stray N; Sauar J; Schreiber S; Moum B; Vatn MH;
Inflamm Bowel Dis; 2009 Mar; 15(3):406-14. PubMed ID: 19009607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
